Abstract
The finding of acquired chromosomal translocations that are consistently associated with specific tumour types supports the premise of lineage-specific mechanisms of tumorigenesis. We review the evidence indicating that the specificity of these translocations and the corresponding gene fusions is related to biological constraints at the level of recombination, expression, and protein function. A dynamic relationship between the gene fusion and the cellular environment is proposed in which the environment influences the selection of oncogenic fusions and the oncogenic fusion in turn influences the cellular environment.
Similar content being viewed by others
References
Daley, G.Q. & Ben-Neriah, Y. Implicating the bcr/abl gene in the pathogenesis of Philadelphia Chromosome-positive human leukemia. Adv. Cancer Res. 57, 151–184 (1991)
Knezevich, S.R., McFadden, D.E., Tao, W., Lim, J.F. & Sorensen, P.H.B. A novel ETV6-NRTK3 gene fusion in congenital fibrosarcoma . Nature Genet. 18, 184–187 (1998)
Rabbits, T.H. Chromosomal translocations in human cancer. Nature 372, 143–149 (1994)
Lowy, D.R. & Willumsen, B.M. Function and regulation of ras . Annu. Rev. Biochem. 62, 851–891 (1993)
Levine, A.J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997)
Nucifora, G. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86, 1–14 ( 1995)
Barr, F.G. Molecular genetics and pathogenesis of rhabdomyosarcoma. J. Ped. Hemat. Oncol. 19, 483–491 (1997)
Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321–330 ( 1996)
Dei Tos, A.P. & Dal Cin, P. The role of cytogenetics in the classification of soft tissue tumors. Virchows Arch. 431, 83–94 (1997)
May, W.A. et al.The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393–7398 (1993)
Zinszner, H., Albalat, R. & Ron, D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8, 2513–2526 (1994)
Daley, G.Q., McLaughlin, J., Witte, O.N. & Baltimore, D. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237, 532–535 (1987)
Shore, S.K., La Cava, M., Yendapalli, S. & Reddy, E.P. Structural alterations in the carboxyl-terminal domain of the BCRABL gene product activate its fibroblastic transforming potential. J. Biol. Chem. 269, 5413–5419 (1994)
Renshaw, M.W., McWhirter, J.R. & Wang, J.Y.J. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation . Mol. Cell. Biol. 15, 1286–1293 (1995)
Sanchez-Garcia, I. & Grutz, G. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc. Natl. Acad. Sci. USA 92, 5287–5291 ( 1995)
Grignani, F. et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423–431 ( 1993)
Kuroda, M. et al. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am. J. Pathol. 151, 735–744 (1997)
Fu, X. & Kamps, M.P. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol. Cell. Biol. 17, 1503 –1512 (1997)
Ferrucci, P.R. et al. Cell death induction by the acute promyelocytic leukemia-specific PML/RARα fusion protein. Proc. Natl. Acad. Sci. USA 94, 10901–10906 (1997)
Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88,593–602 ( 1997)
Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 (1992)
Heisterkamp, N., Jenster, G., Kioussis, D., Pattengale, P.K. & Groffen, J. Human bcr-abl gene has a lethal effect on embryogenesis. Transgenic Res. 1, 45–53 (1991)
Voncken, J.W. et al. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 86, 4603–4611 ( 1995)
David, G., Terris, B., Marchio, A., Lavau, C. & Dejean, A. The acute promyelocytic leukemia PML-RARα protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice. Oncogene 14, 1547–1554 ( 1997)
Grisolano, J.L., Wesselschmidt, R.L., Pelicci, P.G. & Ley, T.J. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood 89, 376–387 ( 1997)
Brown, D. et al. A PMLRARα transgene initiates murine acute promyelocytic leukemia . Proc. Natl. Acad. Sci. USA 94, 2551–2556 (1997)
Early, E. et al. Transgenic expression of PML/RARα impairs myelopoiesis. Proc. Natl. Acad. Sci. USA 93, 7900–7904 (1996)
Castellanos, A. et al. A BCR-ABLp190 fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90, 2168–2174 (1997)
Corral, J. et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85, 853–861 (1996)
Yergeau, D.A. et al. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genet. 15, 303–306 (1997)
Castilla, L.H. et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87, 687–696 (1996)
Haluska, F.G., Finger, L.R., Kagan, J. & Croce, C.M. Molecular genetics of chromosomal translocations in B- and T-lymphoid malignancies. in Molecular Genetics in Cancer Diagnosis (ed. Cossman, J.) 143–162 (Elsevier, New York, 1990)
Chissoe, S.L. et al. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27, 67–82 ( 1995)
Wang, P., Zhou, R.-H., Zou, Y., Jackson-Cook, C.K. & Povirk, L.F. Highly conservative reciprocal translocations formed by apparent joining of exchanged DNA double-strand break ends. Proc. Natl. Acad. Sci. USA 94, 12018–12023 (1997)
Roth, D.B. & Wilson, J.H. Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol. Cell. Biol. 6, 4295–4304 (1986)
Aplan, P.D., Chervinsky, D.S., Stanulla, M. & Burhans, W.C. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87, 2649–58 (1996)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barr, F. Translocations, cancer and the puzzle of specificity. Nat Genet 19, 121–124 (1998). https://doi.org/10.1038/475
Issue Date:
DOI: https://doi.org/10.1038/475
- Springer Nature America, Inc.
This article is cited by
-
Human cell transformation by combined lineage conversion and oncogene expression
Oncogene (2021)
-
Non-reciprocal chromosomal bridge-induced translocation (BIT) by targeted DNA integration in yeast
Chromosoma (2005)
-
Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia
Oncogene (2004)
-
Origins of chromosome translocations in childhood leukaemia
Nature Reviews Cancer (2003)
-
The Pathogenetic Role of Oncogenes Deregulated by Chromosomal Translocation in B-Cell Malignancies
International Journal of Hematology (2003)